| DFMGX | PMBMX | DFMGX / PMBMX | |
| Total Expense Ratio | 0.85 | 1.14 | 75% |
| Annual Report Gross Expense Ratio | 0.92 | 1.14 | 81% |
| Fund Existence | 8 years | 25 years | - |
| Gain YTD | 1.813 | -3.647 | -50% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 331M | 29.8B | 1% |
| Annual Yield % from dividends | 0.00 | 0.02 | - |
| Returns for 1 year | -3.91 | -11.67 | 33% |
| Returns for 3 years | 34.01 | 26.96 | 126% |
| Returns for 5 years | 9.52 | 18.62 | 51% |
| Returns for 10 years | N/A | 86.14 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| UIPMX | 48.77 | 1.61 | +3.41% |
| Victory Precious Metals & Minerals Instl | |||
| MEFNX | 10.78 | 0.10 | +0.94% |
| MassMutual Mid Cap Growth R3 | |||
| RCGHX | 16.99 | 0.13 | +0.77% |
| Virtus KAR Health Sciences C | |||
| JMNAX | 14.92 | -0.02 | -0.13% |
| JPMorgan Research Market Neutral A | |||
| PRGFX | 108.91 | -14.69 | -11.89% |
| T. Rowe Price Growth Stock | |||